Intrexon Raises $100 M of Series E Funding

  • Posted By:
  • 0 Comments... What do you have to say?


E Round: $100,000,000

Founded: 1998
Industry: Mobile

More Here

Blacksburg, Virginia – Intrexon Corporation, a next generation biotechnology company announced that it has raised a huge Series E funding of $100 M from new venture capital firm Perella Weinberg Partners and backed up by existing investors. The new funding brings the company’s total capital funding to more than $259 million.

The latest funding will be utilized on Intrexon’s commercial divisions and the expansion of its UltraVector® platform.

UltraVector platform is the underlying architecture and construction methodology for the company’s complex transgenes, is the backbone of Intrexon’s activities in human health care, animal science, agricultural biotechnology and industrial products.


Funding Total: $100,000,000

Round Date Amount Pre Amount Post Amount
E 05/2011 $100,000,000
Investors: Perella Weinberg Partners

See all fundings here


See an Error? Contact Us

Comments are closed.

venture capital update google plus page Get updates on Google Plus
venture capital update on facebook Get updates on Facebook
venture capital update on twitter Follow fundings on Twitter
venture capital update on pinterest Visit our Pinterest Page

Subscribe here
TwitterCounter for @longest

Follow here

Venture Capital News


Site Information

    About: I work at Phase One Accelerators and you can find me on and at Brian Longest on LinkedIn.

    Share Us on